Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 15;14(1):e1-e6.
doi: 10.4102/phcfm.v14i1.3736.

Serum prostate specific antigen is a good indicator of prostatic volume in men with benign prostatic hyperplasia

Ebenezer Abotsi  1 , Kekeli K Adanu, Eyram C Bansah
Affiliations

Serum prostate specific antigen is a good indicator of prostatic volume in men with benign prostatic hyperplasia

Ebenezer Abotsi et al. Afr J Prim Health Care Fam Med. .

Abstract

Background: Benign prostatic hyperplasia (BPH) is the most common cause of bladder outlet obstruction in men over the age of 50 years. An association between the prostate specific antigen (PSA), International Prostate Symptoms Score (IPSS) and prostate volume (PV) may be instrumental in determining patients who may benefit from treatment. Targeted therapy will reduce the cost of care because it is unwise to treat all men with prostate enlargement to prevent complications when the risk of occurrence is negligible.

Aim: To determine the correlation between the PSA, IPSS and PV in men of African descent.

Setting: This was a cross sectional analysis involving 92 patients diagnosed as having symptomatic BPH at the Ho Teaching Hospital.

Methods: The data were collected using standardised questionnaires. The IPSS determined urinary symptom severity. The PV was determined using a transabdominal ultrasound machine. Serum PSA was retrieved from the electronic medical records.

Results: The mean PV was 61.04 cm3 ± 21.95 cm3, the mean PSA was 4.21 ng/mL ± 3.85 ng/mL, and mean IPSS of 21.59 ± 3.78. The Pearson's correlation between PV and PSA was 0.283 (p = 0.01), between PV and IPSS was 0.108 (p = 0.30), and finally, between Serum PSA and IPSS Score was -0.086 (p = 0.42).

Conclusion: This study showed that serum PSA has a positive correlation with PV. However, IPSS had no significant association with PSA or PV in patients with BPH.Contribution: This study provides insights into the implications of clinical parameters on the management of prostate enlargement.

Keywords: PSA; benign prostatic hyperplasia.; correlation; prostate volume; symptom severity.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no financial or personal relationships that may have inappropriately influenced them in writing this article.

Figures

FIGURE 1
FIGURE 1
A scatter diagram of prostate volume against serum PSA.
FIGURE 2
FIGURE 2
A scatter diagram of serum PSA and IPSS.
FIGURE 3
FIGURE 3
A scatter diagram of prostate volume and IPSS.
See this image and copyright information in PMC

References

    1. Cao Y, Wang Y, Guo L, Yang X, Chen T, Niu H. A randomized, open-label, comparative study of efficacy and safety of tolterodine combined with tamsulosin or doxazosin in patients with benign prostatic hyperplasia. Med Sci Monit. 2016;22:1895–1902. 10.12659/MSM.896283 - DOI - PMC - PubMed
    1. Roehrborn CG. Benign prostatic hyperplasia: An overview. Rev Urol. 2005;7(Suppl 9):S3. 10.1038/ncpuro0553 - DOI - PMC - PubMed
    1. Lepor H. Alpha-blockers for the treatment of benign prostatic hyperplasia. Urol Clin North Am. 2016;43(3):311–323. 10.1016/j.ucl.2016.04.009 - DOI - PubMed
    1. Chughtai B, Forde JC, Dana D, et al. Benign prostatic hyperplasia. Nat Publ Gr. 2016;2:1–15. 10.1038/nrdp.2016.31 - DOI - PubMed
    1. Catalona WJ. History of the discovery and clinical translation of prostate-specific antigen. Asian J Urol. 2014;1(1):12–14. 10.1016/j.ajur.2014.09.008 - DOI - PMC - PubMed

Substances

LinkOut - more resources